BioNexus Gene Lab Corp Common stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,630 | $1,974 | $2,381 | $2,273 |
Gross Profit | 326 | 288 | 344 | 266 |
EBITDA | -1,288 | 290 | -49 | |
EBIT | -1,337 | 259 | -79 | |
Net Income | -1,345 | 199 | -103 | 307 |
Net Change In Cash | 2,630 | 1,974 | 2,381 | 2,273 |
Free Cash Flow | -1,658 | -662 | -50 | -262 |
Cash | 4,137 | 5,414 | 5,832 | 5,929 |
Basic Shares | 17,967 | 17,667 | 17,667 | 17,667 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $9,770 | $10,928 | $13,362 | $11,390 |
Gross Profit | 1,329 | 1,259 | 2,193 | 1,719 |
EBITDA | -2,485 | -185 | 1,164 | 1,375 |
EBIT | -2,593 | -291 | 1,055 | 1,273 |
Net Income | -2,629 | -355 | 751 | 1,094 |
Net Change In Cash | 9,770 | 10,928 | 13,362 | 11,390 |
Cost of Revenue | -509 | 1,928 | ||
Free Cash Flow | -1,450 | 489 | 5 | 131 |
Cash | 5,929 | 2,118 | 2,123 | 2,787 |
Basic Shares | 15,875 | 14,409 | 14,268 | 8,576 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.07 |
2024-06-30 | $0.01 |
2024-03-31 | -$0.005 |
2023-12-31 | $0.01 |
